Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Teladoc Inc Stock Research

TDOC

19.07USD+0.29(+1.54%)Market Closed
Watchlist

Market Summary

USD19.07+0.29
Market Closed
1.54%

TDOC Alerts

  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

TDOC Stock Price

TDOC RSI Chart

TDOC Valuation

Market Cap

3.1B

Price/Earnings (Trailing)

-0.78

Price/Sales (Trailing)

1.24

EV/EBITDA

-0.59

Price/Free Cashflow

13.75

TDOC Price/Sales (Trailing)

TDOC Profitability

EBT Margin

-285.65%

Return on Equity

-307.88%

Return on Assets

-163.7%

Free Cashflow Yield

7.27%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.5B

Revenue Y/Y

10.13%

Revenue Q/Q

3.68%

TDOC Earnings

Earnings (TTM)

-4.0B

Earnings Y/Y

97.9%

Earnings Q/Q

5.85%

Price Action

52 Week Range

18.5534.73
(Low)(High)

Last 7 days

-8.2%

Last 30 days

-13.5%

Last 90 days

-21.7%

Trailing 12 Months

-29.3%

TDOC Financial Health

Current Ratio

3.37

TDOC Investor Care

Shares Dilution (1Y)

2.17%

Diluted EPS (TTM)

-24.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for TDOC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-18
Trencher Daniel
sold
-21,000
21.00
-1,000
chief strategy officer
2023-09-05
Verstraete Stephany
sold
-11,584
22.894
-506
chief marketing officer
2023-09-05
Turitz Andrew
sold
-9,066
22.894
-396
evp, corporate development
2023-09-05
Napolitano Richard J
sold
-14,858
22.894
-649
chief accounting officer
2023-09-05
Trencher Daniel
sold
-9,752
22.894
-426
chief strategy officer
2023-09-05
Geshuri Arnnon
sold
-9,340
22.894
-408
chief people officer
2023-09-05
Vandervoort Adam C
sold
-22,001
22.894
-961
chief legal officer, secretary
2023-09-05
Murthy Mala
sold
-73,741
22.894
-3,221
chief financial officer
2023-09-05
GOREVIC JASON N
sold
-65,568
22.894
-2,864
chief executive officer
2023-09-05
Jensen Claus Torp
sold
-47,917
22.894
-2,093
chief innovation officer

1–10 of 50

Which funds bought or sold TDOC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-21
Baystate Wealth Management LLC
reduced
-84.75
-1,300
228
-%
2023-09-20
BARCLAYS PLC
reduced
-18.44
-1,800,000
7,088,000
-%
2023-09-13
CGC Financial Services, LLC
new
-
2,735
2,735
-%
2023-09-12
Farther Finance Advisors, LLC
added
284
3,792
5,165
-%
2023-09-07
Triatomic Management LP
new
-
303,865
303,865
0.31%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
-3.00
127
-%
2023-08-25
Brown Shipley& Co Ltd
unchanged
-
-174
7,596
-%
2023-08-23
Stonebridge Capital Advisors LLC
reduced
-33.33
-136
253
-%
2023-08-23
WOLVERINE TRADING, LLC
reduced
-59.87
-314,421
222,579
-%
2023-08-22
Asset Dedication, LLC
unchanged
-
-
1,000
-%

1–10 of 38

Latest Funds Activity

Are funds buying TDOC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TDOC
No. of Funds

Schedule 13G FIlings of Teladoc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 10, 2023
vanguard group inc
10.58%
17,313,528
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
14,476,155
SC 13G/A
Feb 07, 2023
blackrock inc.
6.2%
9,961,219
SC 13G/A
Feb 03, 2023
sumitomo mitsui trust holdings, inc.
5.01%
8,125,231
SC 13G/A
Jul 05, 2022
baillie gifford & co
4.80%
7,739,623
SC 13G/A
Mar 11, 2022
blackrock inc.
5.9%
9,485,340
SC 13G/A
Feb 14, 2022
nikko asset management americas, inc.
5.47%
8,755,058
SC 13G
Feb 09, 2022
ark investment management llc
11.82%
18,922,198
SC 13G/A
Feb 08, 2022
blackrock inc.
5.9%
9,485,340
SC 13G
Feb 04, 2022
sumitomo mitsui trust holdings, inc.
5.70%
9,140,808
SC 13G

Recent SEC filings of Teladoc

View All Filings
Date Filed Form Type Document
Sep 21, 2023
3
Insider Trading
Sep 21, 2023
4
Insider Trading
Sep 20, 2023
8-K
Current Report
Sep 19, 2023
4
Insider Trading
Sep 18, 2023
144
Notice of Insider Sale Intent
Sep 06, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading

Peers (Alternatives to Teladoc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
69.5B
61.9B
-6.86% 32.91%
12.04
1.12
3.02% -11.37%
32.6B
2.2B
7.84% 25.45%
60.36
14.6
11.56% 37.20%
18.5B
14.1B
-1.78% -1.24%
22.25
1.31
-5.68% -58.27%
MID-CAP
3.1B
2.5B
-13.48% -29.29%
-0.78
1.24
13.30% 59.30%
2.2B
1.2B
-16.22% -43.97%
-94.57
1.77
-1.77% -138.27%
SMALL-CAP
1.6B
678.1M
31.70% 39.80%
673.28
2.34
12.34% 2970.73%
1.4B
-
-6.26% -24.54%
22.47
1.63
- -
968.3M
319.4M
-31.79% -26.49%
-6.35
3.03
30.27% 15.64%
810.6M
55.7M
-9.54% -15.99%
78.03
14.56
7.05% -12.17%
556.4M
284.6M
-14.95% 5.35%
-3.78
1.95
7.33% -1.68%
278.7M
338.1M
0.29% 133.56%
-2.92
0.82
22.28% 17.91%
136.5M
61.6M
-0.40% -46.39%
-9.51
2.22
-4.03% -105.54%
3.2M
4.0M
-3.26% -70.96%
-2.61
0.79
-9.26% 59.77%

Teladoc News

Best Stocks
Increasing Stake in Teladoc Health: A Prominent Player in Virtual ....
Best Stocks,
58 minutes ago
The Motley Fool
The Motley Fool

Returns for TDOC

Cumulative Returns on TDOC

0.4%


7-Year Cumulative Returns

-24.7%


5-Year Cumulative Returns

-55.7%


3-Year Cumulative Returns

Risks for TDOC

What is the probability of a big loss on TDOC?

97.7%


Probability that Teladoc stock will be more than 20% underwater in next one year

71.2%


Probability that Teladoc stock will be more than 30% underwater in next one year.

62.7%


Probability that Teladoc stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TDOC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Teladoc was unfortunately bought at previous high price.

Drawdowns

Financials for Teladoc

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue2.4%2,530,761,0002,470,734,0002,406,840,0002,323,366,0002,233,622,0002,144,382,0002,032,707,0001,861,793,0001,628,947,0001,366,838,0001,093,962,000867,130,000716,287,000605,533,000553,307,000519,559,000492,552,000456,836,000417,907,000372,306,000329,994,000
Gross Profit------------------310,280,000289,172,000260,883,000235,996,000
  S&GA Expenses-2.0%218,933,000223,333,000227,172,000230,223,000238,191,000244,117,000250,581,000285,193,000246,074,000200,905,000154,052,00076,861,00069,498,00066,643,00064,915,00062,673,00062,856,00061,583,00059,154,00055,924,00051,014,000
  R&D Expenses2.6%339,685,000331,072,000333,629,000326,790,000319,225,000321,288,000311,884,000331,714,000281,422,000223,692,000164,941,00088,490,00074,278,00067,914,00064,644,00061,942,00059,773,00057,456,00054,373,00051,275,00047,662,000
EBITDA100.0%--6,791,020,000-13,416,586,000-9,709,548,000-9,743,248,000-6,795,388,000-260,782,000-697,081,000-691,608,000-623,303,000-566,448,000-122,914,000-106,429,000-101,576,000-99,516,000------
EBITDA Margin100.0%--2.75-5.57-4.18-4.36-3.17-0.13-0.37-0.42-0.46-0.52-0.14-0.15-0.17-0.18------
Interest Expenses2.8%10,030,0009,757,000-9,270,000-20,136,000-37,685,000-63,720,000-80,365,000-82,594,000-80,669,000-73,458,000-59,950,000-46,431,000-37,161,000-31,110,000-29,013,000-28,095,000-28,061,000-27,760,000-26,112,000-27,262,000-27,798,000
Earnings Before Taxes43.0%-4,021,235,000-7,057,755,000-13,663,343,000-9,912,157,000-9,918,207,000-6,946,181,000-384,656,000-803,354,000-760,831,000-658,289,000-575,993,000-119,738,000-109,208,000-110,361,000-109,455,000-110,786,000-106,586,000-102,409,000-96,966,000-117,503,000-125,259,000
EBT Margin100.0%--2.86-5.68-4.27-4.44-3.24-0.19-0.43-0.47-0.48-0.53-0.14-0.15-0.18-0.20------
Net Income43.0%-4,017,952,000-7,054,236,000-13,659,531,000-9,860,445,000-9,871,309,000-6,903,667,000-428,793,000-811,775,000-763,319,000-655,182,000-485,136,000-110,213,000-94,675,000-98,317,000-98,864,000-104,699,000-107,617,000-103,372,000-97,084,000-116,588,000-124,654,000
Net Income Margin100.0%--2.86-5.68-4.24-4.42-3.22-0.21-0.44-0.47-0.48-0.44-0.13-0.13-0.16-0.18------
Free Cashflow-100.0%-219,265,000172,812,000193,743,000209,937,000169,937,000185,456,000-10,917,000-55,338,000-70,394,000-57,535,00076,012,00056,939,00027,540,00026,359,000------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets0.2%4,3164,3094,3458,1048,10311,09217,73517,65317,61117,58217,7553,4492,4191,6031,6031,5681,5651,5521,5291,5351,200
  Current Assets2.7%1,3211,2871,3151,2881,2571,2081,2251,1571,1051,0321,0601,3101,403596588558533541533523179
    Cash Equivalents7.9%9598899189008818368938247847207331,1871,309508514475440434424458106
  Inventory-25.6%34.0046.0056.0059.0060.0071.0073.0057.0057.0058.0056.0012.00---------
  Net PPE2.0%30.0030.0030.0027.0027.0028.0027.0027.0028.0028.0029.0020.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
  Goodwill0%1,0731,0731,0734,8464,8587,90014,50414,47014,45514,45214,5811,691900734746738748734737744745
  Current Liabilities0.5%38338140041137130733130227626033320112497.0090.0085.0070.0072.0062.0058.0057.00
    LT Debt, Current-----------43.00----------
Shareholder's Equity0.2%2,2952,2912,3086,0536,0859,14316,04615,98816,00115,82915,8842,2311,2951,0001,0149941,0031,0021,0131,028699
  Retained Earnings-0.4%-15,142-15,077-15,008-11,198-11,124-8,023-1,421-1,410-1,326-1,192-992-598-562-537-507-488-468-438-408-383-360
  Additional Paid-In Capital0.4%17,47617,41017,35917,30017,23917,17717,47317,39917,31517,01716,8582,8351,8801,5721,5391,5101,4831,4571,4351,4161,062
Shares Outstanding0.6%16516416316216116116015915615215078.0077.0073.0073.0072.0072.0071.0066.0068.0063.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations3.7%243234189207221180194-4.15-48.55-65.22-53.5180.0061.0031.0030.0014.0011.001.00-4.86-14.61-36.54
  Share Based Compensation2.3%20820321822924527730365560554447680.0076.0071.0067.0061.0056.0049.0044.0048.0042.00
Cashflow From Investing4.4%-177-185-167-133-127-84.52-72.98-466-587-595-590-1671.006.0025.00-26.88-39.61-274-257-206-647
Cashflow From Financing78.8%13.007.006.009.009.0022.0041.0010510486685979980739.0035.0033.00365644646597381

TDOC Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenue$ 652,406$ 592,379$ 1,281,650$ 1,157,729
Expenses:    
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)190,540182,470380,647369,495
Operating expenses:    
Advertising and marketing178,756164,574355,546298,174
Sales53,53057,930108,020116,259
Technology and development87,30978,696174,294166,108
General and administrative125,841112,998239,986217,921
Acquisition, integration, and transformation costs5,0802,89211,0247,399
Restructuring costs7,530015,6320
Depreciation and amortization75,46559,371145,248118,304
Goodwill impairment03,030,00009,630,000
Total expenses724,0513,688,9311,430,39710,923,660
Loss from operations(71,645)(3,096,552)(148,747)(9,765,931)
Interest income(11,558)(1,225)(20,469)(1,389)
Interest expense5,8355,56211,09811,206
Other expense (income), net2071,760(4,700)1,036
Loss before provision for income taxes(66,129)(3,102,649)(134,676)(9,776,784)
Provision for income taxes(952)(1,188)(271)(800)
Net loss(65,177)(3,101,461)(134,405)(9,775,984)
Other comprehensive income (loss), net of tax:    
Currency translation adjustment and other2,217(18,440)3,996(23,579)
Comprehensive loss$ (62,960)$ (3,119,901)$ (130,409)$ (9,799,563)
Net loss per share, basic (in dollars per share)$ (0.40)$ (19.22)$ (0.82)$ (60.72)
Net loss per share, diluted (in dollars per share)$ (0.40)$ (19.22)$ (0.82)$ (60.72)
Weighted-average shares used to compute basic net loss per share (in shares)164,171,372161,377,695163,550,481161,002,075
Weighted-average shares used to compute diluted net loss per share (in shares)164,171,372161,377,695163,550,481161,002,075

TDOC Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 958,695$ 918,182
Accounts receivable, net of allowance for doubtful accounts of $8,050 and $4,324, respectively215,181210,554
Inventories34,05456,342
Prepaid expenses and other current assets113,034130,310
Total current assets1,320,9641,315,388
Property and equipment, net30,39229,641
Goodwill1,073,1901,073,190
Intangible assets, net1,784,1051,836,765
Operating lease - right-of-use assets34,82441,831
Other assets72,93048,540
Total assets4,316,4054,345,355
Current liabilities:  
Accounts payable16,07147,690
Accrued expenses and other current liabilities192,937168,693
Accrued compensation67,00181,554
Deferred revenue-current107,385101,832
Total current liabilities383,394399,769
Other liabilities1,7401,618
Operating lease liabilities, net of current portion36,80938,042
Deferred revenue, net of current portion14,24011,954
Deferred taxes, net48,09750,939
Convertible senior notes, net1,536,9811,535,288
Commitments and contingencies (Note 11)
Stockholders’ equity:  
Common stock, $0.001 par value; 300,000,000 shares authorized; 164,877,180 shares and 162,840,360 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively165163
Additional paid-in capital17,476,45117,358,645
Accumulated deficit(15,142,692)(15,008,287)
Accumulated other comprehensive loss(38,780)(42,776)
Total stockholders’ equity2,295,1442,307,745
Total liabilities and stockholders’ equity$ 4,316,405$ 4,345,355
Jason N. Gorevic
5100
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.